// App-Quantinova.ai

e19044 : The prognostic impact of serum albumin in double hit/double expressing aggressive B cell lymphomas: A pilot study evaluating SAAB scoring system.

Researchers

Presenter

  • Chetasi Talati

Principal Investigators

  • Jose David Sandoval-Sus

  • Samir Dalia

  • Bijal D. Shah

  • Celeste M. Bello

  • Paul A. Chervenick

  • Ernesto Ayala

  • Frederick Lundry Locke

  • Mohamed A. Kharfan-Dabaja

  • Eduardo M. Sotomayor

  • Lubomir Sokol

  • Julio C. Chavez

Medical Centers

  • University of South Florida/Moffitt Cancer Center, Tampa, FL

  • Moffitt Cancer Center, Tampa, FL

  • Mercy Clinic Joplin, Joplin, MO

  • Moffitt Cancer Ctr Univ of S Florida, Tampa, FL

  • University of South Florida, Tampa, FL

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • American University of Beirut Medical Center, Riad El Solh, Beirut, Lebanon

  • Georgetown University, Washington, DC

Locations

  • United States

  • Lebanon

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Lymphocytopenia

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved